Article

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease

2020-12-05

Abstract excerpt

<h4>Background: </h4> Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer’s disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carriers are young individuals who are destined to develop AD in future due to the full penetrance of the genetic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c93fd433-5bde-5e91-a5ed-8cd47c117f0a
DOI: 10.21203/rs.3.rs-53396/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s diseaseDOI 10.21203/rs.3.rs-53396/v4Read

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.Semantic proximity Read

Beyond memory impairment: the complex phenotypic landscape of Alzheimer's disease.Semantic proximity Read

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.Semantic proximity Read

Toward Precision Neuropsychiatry of Dementia: Neuropsychiatric Symptoms as Multidimensional Clinical Phenotypes.Semantic proximity Read

Neuropsychiatric symptom phenotypes for early detection of risk in older adults.Semantic proximity Read

Impact of Modifiable Risk Factors and APOE on Neuropsychiatric Symptoms in Alzheimer’s DiseaseSemantic proximity Read

Blood biomarker profiles in young-onset neurocognitive disorders: a cohort studySemantic proximity Read

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.Semantic proximity Read

GWAS links<i>APOE</i>to neuropsychiatric symptoms in mild cognitive impairment and dementiaSemantic proximity Read

Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.Semantic proximity Read

Apathy and Affective Symptoms Associated with Elevated Alzheimer’s Disease BiomarkersSemantic proximity Read

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegenerationSemantic proximity Read